Sterling Capital Management’s Sana Biotechnology SANA Stock Holding History

Sterling Capital Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.25K	Sell	645 -4,464	-87%	-$14.4K	﹤0.01%	2964
2026 Q1	$14.7K	Sell	5,109 -3,440	-40%	-$13.6K	﹤0.01%	2172
2025 Q4	$34.8K	Buy	8,549 +342	+4%	+$1.53K	﹤0.01%	1941
2025 Q3	$29.1K	Buy	8,207 +4,974	+154%	+$18K	﹤0.01%	1968
2025 Q2	$8.83K	Buy	3,233 +3,099	+2,313%	+$6.39K	﹤0.01%	2212
2025 Q1	$225	Hold	134	–	–	﹤0.01%	3071
2024 Q4	$218	Hold	134	–	–	﹤0.01%	3115
2024 Q3	$557	Buy	+134	New	+$704	﹤0.01%	2816

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Sterling Capital Management's SANA Position: Q2 2026 in Review

Sterling Capital Management reduced its Sana Biotechnology (SANA) stake by 87% in Q2 2026, selling an estimated $14.4K and leaving 645 shares worth $2.25K. The position accounts for ﹤0.01% of the portfolio, ranked #2964.

Sterling Capital Management first reported a position in SANA in Q3 2024 and has held it in 8 quarters since. The position peaked at $34.8K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Sterling Capital Management held 645 shares of Sana Biotechnology worth $2.25K as of Q2 2026.
Sterling Capital Management sold 4,464 Sana Biotechnology shares in Q2 2026, an estimated $14.4K.
Sana Biotechnology made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2964 holding.
Sterling Capital Management first reported a position in Sana Biotechnology in Q3 2024 and has held it in 8 quarters since.
Sterling Capital Management's Sana Biotechnology position peaked at $34.8K in Q4 2025.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.